will be changed to the last business day prior to such exercise date. Notification Period The warrantholders who wish to exercise the Warrants shall notify their intention for the exercise of the
Characteristics of the Transaction: The company will purchase 100% of the ordinary shares of Modern Pharma Company Limited in accordance to the agreement in the Share Purchase Agreement. Prior to proceeding with
the Stock Exchange of Thailand (the “SET”) for the past seven but not more than 15 consecutive business days prior to the date on which the Board of Directors of the Company has resolved to propose the
audited by the auditor as of 30 June 2015 which was the most recent financial statement prior to the date of the transaction. Consequently the Company’s Board of Directors' meeting No. 7/2016 on June 29
statement audited by the auditor as of 30 June 2015 which was the most recent financial statement prior to the date of the transaction. Consequently the Company’ s Board of Directors' meeting No. 7/ 2016 on
prior to performing function, except for any of the following cases: 1. the intermediary is a financial institution established under other laws and licensed to undertake securities business as prescribed
shareholders’ meeting prior to entering into such transaction. 3 Moreover, the Entire Business Transfer Transaction and the issuance and offering of the newly issued preferred shares and the U-W3 Warrants to UE
directly acquired 1 to 2 years prior to 30 September, 2019 for Baht 317.3 million. The foreclosed properties which had been acquired one to two years before had a total outstanding balance of Baht 227.8
Derivatives Act B.E. 2546 (2003) ; (b) having the qualifications and not possessing the prohibited characteristics as specified in Chapter 3; (c) having obtained an approval from the SEC Office prior to
in Chapter 3; (c) having obtained an approval from the SEC Office prior to performing function, except for any of the following cases: 2 Amended by the Notification of the Capital Market Supervisory